Matteo Trotta - 25 Mar 2026 Form 4 Insider Report for INCYTE CORP (INCY)

Reporting relationship: EVP, GM, Dermatology US
Issuer ticker: INCY
Reported as of: 25 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Mar 2026, 16:13:52 UTC
Prior SEC filing: 21 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Feeney, Attorney-In-Fact

Key filing fact

Matteo Trotta filed Form 4 for INCYTE CORP (INCY) on 26 Mar 2026.

Key facts

This page summarizes Matteo Trotta's Form 4 filing for INCYTE CORP (INCY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Mar 2026, 16:13.

Change

Previous filing in this sequence was filed on 21 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002015975 Primary reporting owner

Trotta Matteo

Relationship: EVP, GM, Dermatology US
Address: 1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature: /s/ Elizabeth Feeney, Attorney-In-Fact
Signature date: 26 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY transaction

Common Stock

Tax liability

Transaction value
Shares: -537
Change %: -3.5%
Price: $92.23^*
Shares after: 14,882
Date: 25 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.

Footnote F2

This includes an aggregate of 11,160 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.